Virtual CRO
Over 20 years of experience in preclinical CRO business


December 21, 2021

Plan for events in 2022

OncoBone has released the schedule for events and conferences for 2022. Next year will take us to a mix of scientific and partnering events, hopefully some of which will be arranged in-person. From this blog post you may read more on what events we are participating in 2022 and what are our aims and expectations […]

Read more

December 2, 2021

Applications of iNSiGHT DXA in bone and metabolic research

Dual-energy X-ray Absorptiometry (DXA) is a widely used imaging technique in bone and metabolic research for quantitating bone mineral density (BMD) and body composition in small animals. After a 20-year history in developing devices for clinical use, in 2019 OsteoSys launched their first small-animal DXA that OncoBone is now proud to distribute to European markets. […]

Read more

November 19, 2021

What is a Virtual CRO?

In today’s world anything can be virtual – including a Contract Research Organization (CRO). To better serve our existing and new clients OncoBone has launched a new Virtual CRO service. This blog post summarizes the Virtual CRO concept and how it works in practice. The idea behind the Virtual CRO concept During the past years […]

Read more

November 3, 2021

Summary of ASMBR Annual meeting and advances in osteoarthritis research

OncoBone attended American Society for Bone and Mineral Research (ASBMR) Annual meeting 2021 virtually. The event was held in hybrid format including an in-person part in San Diego and an online- part open to all attendees. In the event, OncoBone presented a poster titled: “uKnee: a human osteoarthritic (OA) cartilage-on-chip model for efficacy screening of […]

Read more

June 23, 2021

Osteoimmuno-oncology, a novel concept describing interactions in bone metastasis to guide development of novel therapies

OncoBone contributed to an invited review article to the special issue ‘Cancer Immunology: From Molecular Mechanisms to Therapeutic Opportunities’ in the Journal ‘Cells’, published on June 17, 2021. The review article titled ‘Osteoimmuno-Oncology: Therapeutic Opportunities for Targeting Immune Cells in Bone Metastasis‘ describes the novel concept of osteoimmuno-oncology (OIO) for the first time. OIO highlights […]

Read more

May 28, 2021

Working with CROs – lessons to learn from the webinar

OncoBone co-presented in a webinar titled ‘Working with CROs – from selection to managing relationships’ hosted by Biocom on March 30, 2021. OncoBone’s talk covered CRO selection, and featured speakers from Inotiv and Aligos Therapeutics continued about partnerships between CROs and Sponsors. Below is a summary of the key aspects covered in the webinar. There […]

Read more

April 27, 2021

Upcoming webinar: Human Immune System Models in Metastasis Research

OncoBone and Taconic Biosciences will co-present in a webinar titled: ‘Utility of Human Immune System Mice in Metastasis Cancer Drug Development’ on May 4, 2021. Below is a short overview of what to expect from the webinar.

Read more

November 13, 2020

Experiences on virtual scientific events in 2020 and hopes for 2021

Due to COVID-19 pandemic, the year 2020 has been exceptional in many ways. One of the big drawbacks in biomedical research and business has been that all scientific events were transferred to virtual format. OncoBone representatives attended four virtual scientific events this year. In this blog post we summarize our experiences about them and present our hopes for events organized in 2021.

Read more

September 1, 2020

How is it like to start a business during COVID-19 crisis

OncoBone offers scientific expertise especially in the fields of oncology and bone diseases. In this blog we discuss and comment new scientific discoveries, new accomplishments in drug development and emerging technologies, and biomedical business -related issues.

Read more



If you are interested to learn more,
see our services or contact us directly. logo Science Exchange logo

    Copyright © 2024 OncoBone Ltd